FDA approves Lumason for UltraSound Imaging of the heart- Bracco
The FDA has on 10 October 2014 approved Lumason (sulfur hexafluoride lipid microsphere) from Bracco, for patients whose ultrasound image of the heart (echocardiograms) are hard to see with ultrasound waves.Lumason is a contrast agent made up of gas-filled microbubbles (or microspheres) that reflect the sound waves to enhance the image. Lumason helps a physician see a patient’s heart more clearly, allowing for clearer imaging of the left ventricle chamber and the smooth edge on the inside of the chambers of the heart, known as the endocardium.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins